Faeth: PIKTOR pivotal trial design expected 1H 2027 after Phase 2 endometrial data
A November 9 corporate presentation detailed topline PIK-201 results and said pivotal trial design for PIKTOR is expected in the first half of 2027, pending regulatory alignment.
SEC filing, FDA (16)